Novartis has reduced the average price of its antimalarial drug Coartem [artemether/lumefantrine] from an average $US1.5
- PDF / 136,481 Bytes
- 1 Pages / 623.591 x 841.847 pts Page_size
- 26 Downloads / 135 Views
1173-5503/10/0514-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
PharmacoEconomics & Outcomes News 21 Oct 2006 No. 514
1
Data Loading...